← Back
Data updated: Jul 17, 2026
CHASE CHEM
Pharma Pharmaceuticals
CHASE CHEM is a pharmaceutical company with 2 FDA-approved products.
-
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
CHASE CHEM's Key Drugs
CHASE CHEM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CHASE CHEM's Recent FDA Approvals
New NDA/BLA approvals for CHASE CHEM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CHASE CHEM's Therapeutic Areas
Disease areas where CHASE CHEM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CHASE CHEM Pipeline Snapshot
Active clinical trials for CHASE CHEM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 4